Florida Cancer Specialists & Research Institute Fort Myers – Colonial Lab Team Recognized for Quality Laboratory Services

Press Release

The Colonial lab team at Florida Cancer Specialists & Research Institute, LLC  Fort Myer is eligible Laboratory Accreditation by COLA Inc.

Fort Myers, Fla., August 4, 2022 – Florida Cancer Specialists & Research Institute, LLC (FCS) Fort Myers – Colonial lab team has met all the criteria for Laboratory Accreditation by COLA Inc., a leading national laboratory accreditor, whose program and standards enable clinical laboratories and staff to meet United States Clinical Laboratory Improvement Act (CLIA) and other regulatory requirements.

Through a mentoring approach using education to improve quality and patient safety, accreditation is given to laboratories that apply the highest standards of quality in day-to-day operations, demonstrate continued accuracy in the performance of proficiency testing, and pass a rigorous on-site laboratory survey. The FCS Fort Myers – Colonial lab team has earned COLA Inc. accreditation to provide quality service to its patients.

The FCS Ft. Myers – Colonial lab team is also the recipient of the Laboratory Excellence Award, which signifies their commitment in performing quality patient testing and superior overall laboratory practices. Beyond these requirements, the lab had to demonstrate successful proficiency testing for three prior testing events with no substantiated complaints to receive this award.

“The patient experience is influenced at every touchpoint. When our patients have access to a reliable, efficient lab within their clinic, there is a direct correlation to their confidence in our team to deliver high-quality care across the board, and is a reflection of the value we provide,” says FCS President & Managing Physician Michael Diaz, MD.

“Delivering high-quality care extends to every corner of our practice and our labs are no exception. To be recognized for excellence is a team effort and represents our values as a patient-centered organization,” remarked FCS Chief Executive Officer Nathan Walcker. “I commend this team for delivering a high caliber of laboratory services consistently and with excellence.”


About COLA
COLA, Inc. is a physician-directed organization whose purpose is to promote health and safety through accreditation and educational programs. In 1993, COLA was granted deemed status by CMS to provide laboratory accreditation. As a leading laboratory accreditor in the United States, COLA is the only laboratory accreditation provider that operates its accreditation program in accordance with a quality management system certified to ISO 9001:2015. This means we offer our customers a unique, standardized program and staff dedicated to satisfaction and laboratory quality. Our surveyors and technical advisors are guided by a coaching approach and uncomplicated quality engineered processes. Laboratories of all types and sizes are evaluated and mentored to produce accurate test results and meet CLIA regulations.

COLA Inc. is approved by the federal government and sponsored by the American Academy of Family Physicians, the American Medical Association, and the American College of Physicians.

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in prestigious medical schools and research institutes, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Founded in 1984, Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.

*Prior to approval

For More Information, Contact:
Michelle Robey, VP of Marketing
(813) 767-9398

Jennifer Bradley, Director of Corporate Communications
(847) 280-1740

Related Videos
Bradley McGregor, MD, an expert on renal cell carinoma
Experts on renal cell carcinoma
Related Content